Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The document concludes that scalp conditions have various causes and can present in many different ways.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Three compounds from Dadap leaves may help treat hair loss.

Finasteride helps female-pattern hair loss.

Certain immune cells in the skin can stop hair from growing.

Type I interferons play a key role in the development of various skin diseases.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.